- Home
- PODD vs EQR Comparison
PODD vs EQR Comparison
Compare PODD & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PODD | EQR |
|---|---|---|
| Founded | 2000 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1B | 22.5B |
| IPO Year | 2007 | 1993 |
Fundamental Metrics
Financial Performance| Metric | PODD | EQR |
|---|---|---|
| Price | $304.59 | $61.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 11 |
| Target Price | ★ $359.00 | $70.00 |
| AVG Volume (30 Days) | 765.6K | ★ 2.1M |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 4.54% |
| EPS Growth | N/A | ★ 24.49 |
| EPS | ★ 3.45 | 3.03 |
| Revenue | $2,521,800,000.00 | ★ $3,078,827,000.00 |
| Revenue This Year | $32.55 | $5.06 |
| Revenue Next Year | $20.39 | $3.55 |
| P/E Ratio | $88.24 | ★ $20.13 |
| Revenue Growth | ★ 27.11 | 4.69 |
| 52 Week Low | $230.05 | $58.38 |
| 52 Week High | $354.88 | $75.86 |
Technical Indicators
Market Signals| Indicator | PODD | EQR |
|---|---|---|
| Relative Strength Index (RSI) | 40.94 | 50.24 |
| Support Level | $303.20 | $61.02 |
| Resistance Level | $317.34 | $62.42 |
| Average True Range (ATR) | 13.12 | 0.90 |
| MACD | -2.82 | 0.26 |
| Stochastic Oscillator | 3.14 | 62.17 |
Price Performance
Historical ComparisonAbout PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.